IL96064A - History of 2-] 1-Paneoxy-2-phenylalkyl [imidazoline and 2, 2, 3, 4-tetrahydro-pyrimidine and medicinal preparations containing them - Google Patents

History of 2-] 1-Paneoxy-2-phenylalkyl [imidazoline and 2, 2, 3, 4-tetrahydro-pyrimidine and medicinal preparations containing them

Info

Publication number
IL96064A
IL96064A IL9606490A IL9606490A IL96064A IL 96064 A IL96064 A IL 96064A IL 9606490 A IL9606490 A IL 9606490A IL 9606490 A IL9606490 A IL 9606490A IL 96064 A IL96064 A IL 96064A
Authority
IL
Israel
Prior art keywords
represented
benzo
compound according
compounds
integer
Prior art date
Application number
IL9606490A
Other languages
English (en)
Hebrew (he)
Other versions
IL96064A0 (en
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of IL96064A0 publication Critical patent/IL96064A0/xx
Publication of IL96064A publication Critical patent/IL96064A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL9606490A 1989-10-20 1990-10-19 History of 2-] 1-Paneoxy-2-phenylalkyl [imidazoline and 2, 2, 3, 4-tetrahydro-pyrimidine and medicinal preparations containing them IL96064A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42442989A 1989-10-20 1989-10-20

Publications (2)

Publication Number Publication Date
IL96064A0 IL96064A0 (en) 1991-07-18
IL96064A true IL96064A (en) 1994-11-28

Family

ID=23682608

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9606490A IL96064A (en) 1989-10-20 1990-10-19 History of 2-] 1-Paneoxy-2-phenylalkyl [imidazoline and 2, 2, 3, 4-tetrahydro-pyrimidine and medicinal preparations containing them

Country Status (21)

Country Link
EP (1) EP0423802B1 (es)
JP (1) JP3097696B2 (es)
KR (1) KR0182808B1 (es)
CN (1) CN1028099C (es)
AR (1) AR248400A1 (es)
AT (1) ATE126217T1 (es)
AU (1) AU627627B2 (es)
CA (1) CA2027530C (es)
DE (1) DE69021490T2 (es)
DK (1) DK0423802T3 (es)
ES (1) ES2088936T3 (es)
FI (1) FI104717B (es)
GR (1) GR3017775T3 (es)
HU (1) HU207300B (es)
IE (1) IE67049B1 (es)
IL (1) IL96064A (es)
NO (1) NO179367C (es)
NZ (1) NZ235688A (es)
PH (1) PH27290A (es)
PT (1) PT95637B (es)
ZA (1) ZA908234B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0625969B1 (en) * 1992-02-06 2001-03-07 Merrell Pharmaceuticals Inc. Arylalkoxyphenoxy-imidazoline compounds
KR100693139B1 (ko) * 2001-04-19 2007-03-13 엘지전자 주식회사 디스크 드라이브의 트레이 진동방지구조
KR100482010B1 (ko) 2002-11-05 2005-04-14 삼성전자주식회사 모니터장치
EP1958507A1 (en) 2007-02-15 2008-08-20 Syngeta Participations AG Chemical compounds
AU2008270445A1 (en) * 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (TAARs)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE614596C (de) * 1931-07-10 1935-06-13 I G Farbenindustrie Akt Ges Verfahren zur Darstellung von ?-Glyoxalidinarylmethylolen
US2893993A (en) * 1958-06-17 1959-07-07 Searle & Co 2-aryloxyaralkyl-1, 4, 5, 6-tetrahydropyrimidines
US3897431A (en) * 1969-04-24 1975-07-29 Sterling Drug Inc 2-{8 {60 -Alkoxy-arylmethyl{9 -2-imidazolines and -1,4,5,6-tetrahydropyrimidines
AU3546478A (en) * 1977-04-29 1979-11-01 Ciba Geigy Ag Ectoparasiticides
EP0011596B1 (de) * 1978-10-09 1981-12-30 Ciba-Geigy Ag Neue 2-(alpha-Phenoxy-alkyl)-imidazoline und ihre Salze, deren Herstellung und Verwendung sowie sie enthaltende Mittel zur Bekämpfung von pflanzenschädlichen und tierparasitären Milben
US4260626A (en) * 1979-03-26 1981-04-07 Richardson-Merrell Inc. Tetrahydro and imidazoline antisecretory compounds
IT1231237B (it) * 1987-09-21 1991-11-26 Angeli Inst Spa Derivati eterociclici

Also Published As

Publication number Publication date
NZ235688A (en) 1992-02-25
ZA908234B (en) 1991-08-28
AU627627B2 (en) 1992-08-27
DE69021490D1 (de) 1995-09-14
EP0423802B1 (en) 1995-08-09
NO904535D0 (no) 1990-10-19
GR3017775T3 (en) 1996-01-31
CN1028099C (zh) 1995-04-05
ES2088936T3 (es) 1996-10-01
DK0423802T3 (da) 1995-09-18
IE67049B1 (en) 1996-02-21
EP0423802A1 (en) 1991-04-24
PT95637A (pt) 1991-09-13
KR0182808B1 (ko) 1999-05-01
HU906514D0 (en) 1991-04-29
KR910007887A (ko) 1991-05-30
CN1051039A (zh) 1991-05-01
FI104717B (fi) 2000-03-31
DE69021490T2 (de) 1996-02-01
IE903765A1 (en) 1991-04-24
JP3097696B2 (ja) 2000-10-10
HU207300B (en) 1993-03-29
FI905168A0 (fi) 1990-10-19
CA2027530C (en) 2001-05-08
AU6456590A (en) 1991-04-26
AR248400A1 (es) 1995-08-18
HUT55366A (en) 1991-05-28
ATE126217T1 (de) 1995-08-15
IL96064A0 (en) 1991-07-18
JPH03135960A (ja) 1991-06-10
NO179367B (no) 1996-06-17
NO179367C (no) 1996-09-25
CA2027530A1 (en) 1991-04-21
NO904535L (no) 1991-04-22
PH27290A (en) 1993-05-04
PT95637B (pt) 1998-04-30

Similar Documents

Publication Publication Date Title
JPH08501559A (ja) セロトニン受容体剤
KR19990029067A (ko) 피페라진 유도체 및 5­ht1a 길항제로서의 이의용도
CA1111038A (en) Antisecretory compounds
EP0527081B1 (fr) Nouvelles pipérazinylalcoyl-3 dihydro-2,3 4H-benzoxazine-1,3 ones-4 substituées, leur préparation et leur application en thérapeutique
EP1828125B1 (fr) Derives d'arylpiperazine et leur utilisation comme ligands selectifs du recepteur d3 de la dopamine
CA1173044A (en) 2-(1,4-benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
IL96064A (en) History of 2-] 1-Paneoxy-2-phenylalkyl [imidazoline and 2, 2, 3, 4-tetrahydro-pyrimidine and medicinal preparations containing them
FR2756560A1 (fr) Nouveaux derives de l'imidazoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JPH089615B2 (ja) β―カルボリン―3―カルボン酸誘導体、その製造法及び該化合物を含有する精神安定剤
HU187337B (en) Process for producing sbstituted oxo-carboxylic acids and pharmaceutical compositions containing them
JPH068285B2 (ja) 三環式アミン、その製法及び医薬組成物
KR100274103B1 (ko) 5,6,-디하이드로나프토[1,2-b]피란 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물
FR2642755A1 (es)
US5134154A (en) Phenoxy-heterocyclic compounds
US4622336A (en) 3,3-dialkyl-and 3,3-alkylene-indoline derivatives, processes for their production and pharmaceutical compositions comprising them
JPS61100579A (ja) ピリジン誘導体
US4957913A (en) Antihypertensive polycyclic imides
KR850000126B1 (ko) 이미다졸 유도체의 제조방법
US4579845A (en) Antihypertensive cyanoguanidines
US5171857A (en) Antihypertensive benzopyran derivatives
CA2346506C (fr) Derives d'aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone comme agonistes du recepteur 5-ht1
US3998842A (en) Diazepino[1,2-α]indoles
US3996373A (en) 2,3-Dihydro-1H-dibenz[e,g]isoindole compounds
US4497818A (en) 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles useful as antihypertensives and platelet aggregation inhibitors
US5252597A (en) Antihypertensive benzopyran derivatives

Legal Events

Date Code Title Description
KB Patent renewed
HC Change of name of proprietor(s)
HP Change in proprietorship
RH Patent void
MM9K Patent not in force due to non-payment of renewal fees
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INCORPORATED